Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
Nanoparticle drug formulations are currently used as cancer treatment but the response in patients is highly variable. Here, the authors developed a Zirconium-89 nanoreporter able to predict using PET, therapeutic accumulation and efficacy of anti-cancer nanoparticle drug formulations when co-inject...
Guardado en:
Autores principales: | Carlos Pérez-Medina, Dalya Abdel-Atti, Jun Tang, Yiming Zhao, Zahi A. Fayad, Jason S. Lewis, Willem J. M. Mulder, Thomas Reiner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bedddcd02a6645ff8aef2ea1449bb3ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
por: Yiming Zhao, et al.
Publicado: (2016) -
Ormeloxifene nanotherapy for cervical cancer treatment
por: Chauhan N, et al.
Publicado: (2019) -
Molecular targets in arthritis and recent trends in nanotherapy
por: Roy K, et al.
Publicado: (2015) -
Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
por: Yang Liu, et al.
Publicado: (2017) -
Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease
por: Edmund J. Keliher, et al.
Publicado: (2017)